Market revenue in 2023 | USD 34.2 million |
Market revenue in 2030 | USD 47.4 million |
Growth rate | 4.8% (CAGR from 2023 to 2030) |
Largest segment | Crt-defibrillator |
Fastest growing segment | CRT-Pacemaker |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | CRT-Defibrillator, CRT-Pacemaker |
Key market players worldwide | Medtronic PLC, Abbott Laboratories, Boston Scientific Corp, BIOTRONIK, MicroPort Scientific Corp, LivaNova PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cardiac resynchronization therapy market will help companies and investors design strategic landscapes.
Crt-defibrillator was the largest segment with a revenue share of 58.48% in 2023. Horizon Databook has segmented the Saudi Arabia cardiac resynchronization therapy market based on crt-defibrillator, crt-pacemaker covering the revenue growth of each sub-segment from 2018 to 2030.
As per the 2009-2011 HEart function Assessment Registry Trial in Saudi Arabia (HEARTS), 6.6% of patients were implanted with CRT devices at enrollment. This number increased to 8.8% after 1 year. The adoption of CRT devices in Saudi Arabia is comparatively lower than global average. The COVID-19 pandemic further impacted the market.
It led to interruptions in continuity of care for chronic cardiac conditions, such as heart failure patients and cancellation of nonurgent hospital visits. In response, the Saudi Heart Failure Working Group (SAUDI-HF) specified several recommendations to ensure quality and continuity of care for HF patients.
Chronic HF patients in the country commonly have severe LV systolic dysfunction, are younger, with relatively high re-hospitalization rates, and annual mortality. This is anticipated to fuel the market in coming years.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia cardiac resynchronization therapy market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia cardiac resynchronization therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account